Commentary
Fabrice Pothier
{
"authors": [
"Fabrice Pothier"
],
"type": "legacyinthemedia",
"centerAffiliationAll": "dc",
"centers": [
"Carnegie Endowment for International Peace",
"Carnegie Europe"
],
"collections": [
"Transatlantic Cooperation",
"Brexit and UK Politics"
],
"englishNewsletterAll": "ctw",
"nonEnglishNewsletterAll": "",
"primaryCenter": "Carnegie Europe",
"programAffiliation": "SAP",
"programs": [
"South Asia"
],
"projects": [],
"regions": [
"Asia",
"Europe",
"North America",
"Afghanistan",
"Pakistan"
],
"topics": [
"Foreign Policy",
"Economy"
]
}
Source: Getty
In The Media
NATO's Drug Problem
NATO's new war on drugs in Afghanistan will put troops in greater danger for a venture that may not even work. It just might be the straw that breaks the alliance's back.
Published on Oct 15, 2008
Source: The National Interest
Advocates presented this decision as a “tactical adjustment.” But in fact it marks an attempt to militarize our way out of the narcotics problem in Afghanistan. At a time when troops on the ground are stretched thin and the coalition is losing the battle for Afghan hearts and minds, such a radical shift in policy could prove to be NATO's mission-too-far.
No foreign army has ever succeeded in a counternarcotics effort of this kind. Drugs are fundamentally economic and law enforcement issues. At best, military force has made only a marginal impact, and in most cases, it has been counterproductive. Thailand, Burma and, to a lesser extent, Colombia succeeded in eliminating or gaining partial control of their drug trades only after decades of sustained political and economic development efforts. But Thailand, for one, had to offer its farmers a five-year amnesty to switch from illegal to legitimate crops.
(To continue reading, click here)
About the Author
Fabrice Pothier
Former Director, Carnegie Europe
Pothier, director of Carnegie Europe, is a noted commentator on European policy in Afghanistan and Pakistan, transatlantic issues, and global drug policy.
- Can Macron Reload the Minsk Process?
- Where's Europe?Q&A
Fabrice Pothier
Recent Work
Carnegie does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.
More Work from Carnegie China
- The Plaza Accord and Its Relevance for ChinaCommentary
The Plaza Accord was not an externally imposed punishment of Japan but part of a broader restructuring that Japanese economists and policymakers themselves recognized was necessary. Its effects were undermined, however, when Tokyo responded to the resulting slowdown with policies that exacerbated investment, credit expansion, and the very imbalances the adjustment was intended to resolve.
Michael Pettis
- Untangling the Nuclear Knot: A Constructive Agenda for Managing China’s Nuclear Relations with the United States and Its AlliesPaper
The nuclear relationship between China and the United States is increasingly shaped by widening perception gaps rather than deliberate strategic design.
Tong Zhao
- Who Paid for China’s Last Debt Cleanup, and Who Will Pay for the Next?Commentary
China’s banking crisis in the 2000s was resolved by transferring the costs to households through financial repression—a decision that recapitalized the banks while exacerbating the structural imbalances that continue to shape the Chinese economy today.
Michael Pettis
- Caught in the Middle: Chinese Biotech Firms’ Divergent Responses to U.S. SanctionsCommentary
Chinese biotech companies have been on the receiving end of U.S. economic coercion. Yet their responses have differed significantly because firm and state interests are not uniformly aligned. For Washington, treating all Chinese tech firms the same, irrespective of their actual interests, risks pushing them farther into Beijing’s corner.
Xue Gong
- Trump and Xi Are Angling for Three Years of StabilityCommentary
But their "principal to principal" model will only be as effective as the political strength of each leader back home.
Damien Ma
